forty patients with severe parkinson 's disease ( 23 men , 17 women ) who had been treated for six years with l-dopa-decarboxylase inhibitor , were part of a placebo-controlled double-blind trial to test the effectiveness of bromocriptin .
C0030567
parkinson 's disease
C0006230
bromocriptin